Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Foundation for the National Institutes of Health
- Study ID
- NCT07776678
- Status
- Recruiting
Conditions
- Obesity & Overweight
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The purpose of this study is to evaluate body composition across a variety of medical, professional, and commercial devices, including: bioelectrical impedance analysis (BIA) devices, 3-dimensional optical imaging (3DO), manual anthropometry measurements, dual-energy X-ray absorptiometry (DXA), magnetic resonance imaging (MRI), and blood tests. The secondary study purpose is to compare body composition measurements from BIA devices, 3DO, and manual anthropometry measurements within a 1-week period for a subset of the study population. The study plans to enroll 300 healthy (having no life-threatening conditions or diseases; male and female) participants, 18 years of age or older.
Key Dates
- First listed
- Aug 20, 2026
- Start date
- Jun 29, 2026
- Status verified
- Aug 2026
- Primary completion
- Nov 30, 2026
- Completion
- Mar 30, 2027
Study Design
- Enrollment
- 300 participants (estimated)
Primary Outcome Measure
Modality-reference agreement for total fat mass (kg) [ Time Frame: 4 Weeks ]
Central Contacts
- Steven Heymsfield, MD650-688-4070
- Ariel Dowling, PhD650-688-4070
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Exponent Phoenix | Phoenix | Arizona | 85027 | |
| Exponent Menlo Park | Menlo Park | California | 94025 | - |
| Exponent Boston | Boston | Massachusetts | 01760 |
Find similar trials in Phoenix, AZ
Related Studies
- Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" FoodRecruiting · Cambridge Health Alliance · Sommerville, Massachusetts
- Stanford Pediatric Healthy Weight IndexRecruiting · Stanford University · Palo Alto, California
- Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight LossPHASE2 · Recruiting · Veru Inc. · Phoenix, Arizona
- Impact of a Produce Prescription Program and Nutrition Education Intervention on Cardiovascular Health in YouthNot Yet Recruiting · Boston Children's Hospital · Boston, Massachusetts